Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators
Helene J. Bustad, Juha P. Kallio, Marta Vorland, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 675-675
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Givosiran: A Review in Acute Hepatic Porphyria
Yahiya Y. Syed
Drugs (2021) Vol. 81, Iss. 7, pp. 841-848
Closed Access | Times Cited: 66
Dopamine synthesis and transport: current and novel therapeutics for parkinsonisms
Mary Dayne Sia Tai, Gloria Gamiz-Arco, Aurora Martı́nez
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1275-1291
Open Access | Times Cited: 5
A novel HMBS gene mutation in acute intermittent porphyria: a case report of abdominal pain, seizures, and reversible neuroimaging findings
Wentao Dong, Bingliang Zeng, Xiaolian Wang, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Nutrition and rare diseases: a case study of patients with acute intermittent porphyria (AIP)
Francesca Granata, Luisella Vigna, Elena Di Pierro, et al.
Nutrition & Metabolism (2025) Vol. 22, Iss. 1
Open Access
Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
Petro E. Petrides, Michael Klein, Elfriede Schuhmann, et al.
Annals of Hematology (2021) Vol. 100, Iss. 7, pp. 1685-1693
Open Access | Times Cited: 30
Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation
Warren van Loggerenberg, Shahin Sowlati‐Hashjin, Jochen Weile, et al.
The American Journal of Human Genetics (2023) Vol. 110, Iss. 10, pp. 1769-1786
Open Access | Times Cited: 12
Exploring current and emerging therapies for porphyrias
Daniel Jericó, Karol M. Córdoba, F Urigo, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2174-2190
Closed Access | Times Cited: 4
An easily overlooked disease in the early stages: acute intermittent porphyria
Jing Wang, J Chen, Ke Xu, et al.
BMC Neurology (2025) Vol. 25, Iss. 1
Open Access
Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations
Paulo Victor Sgobbi de Souza, Bruno de Mattos Lombardi Badia, Igor Braga Farias, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 26
Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment
Daniel Jericó, Karol M. Córdoba, Ana Sampedro, et al.
Life (2022) Vol. 12, Iss. 11, pp. 1858-1858
Open Access | Times Cited: 15
Development of RNA interference-based therapy for rare genetic diseases
Milya Urfa Ahmad, Syarifah Dewi
Acta Biochimica Indonesiana (2024) Vol. 7, Iss. 1, pp. 171-171
Open Access | Times Cited: 2
Challenges in Treating Genodermatoses: New Therapies at the Horizon
Marie‐Anne Morren, Eric Legius, Fabienne Giuliano, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 12
Evaluation of Metabolic Changes in Acute Intermittent Porphyria Patients by Targeted Metabolomics
Àlex Gomez‐Gómez, Paula Aguilera, Klaus Langohr, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3219-3219
Open Access | Times Cited: 8
Psychological Aspect and Quality of Life in Porphyrias: A Review
Francesca Granata, Annamaria Nicolli, Alessia Colaiocco, et al.
Diagnostics (2022) Vol. 12, Iss. 5, pp. 1193-1193
Open Access | Times Cited: 8
Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know
Petro E. Petrides
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1618-1618
Open Access | Times Cited: 8
A Case of Acute Intermittent Porphyria Leading to Severe Disability in a Young 21-Year-Old Female
Adil Ramzan, Jenny Jia Ling Cao, John Scott Frazer, et al.
Cureus (2023)
Open Access | Times Cited: 4
Transcriptome profile analysis reveals putative molecular mechanisms of 5-aminolevulinic acid toxicity
Patricia Regina Menezes, Carlos Eduardo Madureira Trufen, Flávio Lichtenstein, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 738, pp. 109540-109540
Closed Access | Times Cited: 3
Two Novel Hydroxymethylbilane Synthase Splicing Mutations Predispose to Acute Intermittent Porphyria
Yanping Zhang, Han Xiao, Qiuhong Xiong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11008-11008
Open Access | Times Cited: 6
Intrahepatic Cholangiocarcinoma and Acute Intermittent Porphyria: A Case Report
Claudio Carmine Guida, Maria Nardella, Leonardo Fiorentino, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3091-3091
Open Access | Times Cited: 2
Clinical feature and genetic analysis of HMBS gene in Chinese patients with acute intermittent porphyria: a systematic review
Yi Ren, Shuang Li, Jia-Jia Lei, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
A Perfect Storm: Abdominal Pain and Ileus Explained by Acute Intermittent Porphyria Caused by Prehospitalization and Intrahospitalization Factors
Andrew J. Ortega, Sundar Cherukuri, M Ammar Kalas, et al.
Journal of Investigative Medicine High Impact Case Reports (2022) Vol. 10
Open Access | Times Cited: 4
Characterisation of a common hotspot variant in acute intermittent porphyria sheds light on the mechanism of hydroxymethylbilane synthase function
Marthe S. Christie, Mikko Laitaoja, Aasne K. Aarsand, et al.
FEBS Open Bio (2022) Vol. 12, Iss. 12, pp. 2136-2146
Open Access | Times Cited: 4
Circadian Genes Expression Patterns in Disorders Due to Enzyme Deficiencies in the Heme Biosynthetic Pathway
Michelangelo Savino, Claudio Carmine Guida, Maria Nardella, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3198-3198
Open Access | Times Cited: 4
Acute Intermittent Porphyria: Complete Phenotype in a Patient with p.Arg173Trp Variant in Thailand
Vachiravit Sriprakoon, Chalisa Ittagornpunth, Nakorn Puapaiboon, et al.
American Journal of Case Reports (2022) Vol. 23
Open Access | Times Cited: 3
Effectiveness and tolerability of givosiran for the management of acute hepatic porphyria: A monocenter real-life evaluation
Claudio Carmine Guida, Maria Nardella, Aurora Del Mar Ys Perez, et al.
Molecular Genetics and Metabolism Reports (2024) Vol. 40, pp. 101111-101111
Open Access
Page 1 - Next Page

Scroll to top